Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients (CRIST)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02156765
Recruitment Status : Unknown
Verified June 2014 by yongjun wang, Ministry of Science and Technology of the People´s Republic of China.
Recruitment status was:  Recruiting
First Posted : June 5, 2014
Last Update Posted : June 5, 2014
Sponsor:
Information provided by (Responsible Party):
yongjun wang, Ministry of Science and Technology of the People´s Republic of China

Tracking Information
First Submitted Date June 3, 2014
First Posted Date June 5, 2014
Last Update Posted Date June 5, 2014
Study Start Date October 2013
Estimated Primary Completion Date March 2015   (Final data collection date for primary outcome measure)
Current Primary Outcome Measures
 (submitted: June 4, 2014)
Accumulated detection rate of AF [ Time Frame: 1.5 year ]
ECG was monitored for all patients enrolled in a single center for consecutive 6 days
Original Primary Outcome Measures Same as current
Change History No Changes Posted
Current Secondary Outcome Measures Not Provided
Original Secondary Outcome Measures Not Provided
Current Other Pre-specified Outcome Measures Not Provided
Original Other Pre-specified Outcome Measures Not Provided
 
Descriptive Information
Brief Title China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients
Official Title China Atrial Fibrillation Screening in Acute Ischemic Stroke Patients
Brief Summary

Three purpose of this study:

  1. Increase diagnosis rate and formulate the flow of diagnosis and treatment of AF in ischemic stroke patients;
  2. Evaluation on specificity and sensitivity of STAF score;
  3. Analyze the pathogenesis of ischemic stroke and risk factors and establish clinical database and sample database of ischemic stroke.
Detailed Description

Inclusion criteria:

  1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
  2. Age ≥ 18 years;
  3. Within 7 days after the onset of diseases;
  4. Signed the consent informed form.

Exclusion criteria:

  1. Patients with noncerebrovascular diseases that are diagnosed definitely;
  2. Silent cerebral infarction (CI) without symptoms and signs;
  3. Those refuse to sign the consent informed form of the study.
Study Type Observational [Patient Registry]
Study Design Time Perspective: Prospective
Target Follow-Up Duration 6 Days
Biospecimen Not Provided
Sampling Method Non-Probability Sample
Study Population Hospitalized patients with ischemic stroke that are diagnosed definitely
Condition
  • Atrial Fibrillation
  • Stroke
Intervention Not Provided
Study Groups/Cohorts Not Provided
Publications *

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Recruitment Information
Recruitment Status Unknown status
Estimated Enrollment
 (submitted: June 4, 2014)
3000
Original Estimated Enrollment Same as current
Estimated Study Completion Date March 2015
Estimated Primary Completion Date March 2015   (Final data collection date for primary outcome measure)
Eligibility Criteria

Inclusion Criteria:

  1. Hospitalized patients with ischemic stroke that are diagnosed definitely;
  2. Age ≥ 18 years;
  3. Within 7 days after the onset of diseases;
  4. Signed the consent informed form.

Exclusion Criteria:

  1. Patients with noncerebrovascular diseases that are diagnosed definitely;
  2. Silent cerebral infarction (CI) without symptoms and signs;
  3. Those refuse to sign the consent informed form of the study.
Sex/Gender
Sexes Eligible for Study: All
Ages 18 Years and older   (Adult, Older Adult)
Accepts Healthy Volunteers No
Contacts Contact information is only displayed when the study is recruiting subjects
Listed Location Countries China
Removed Location Countries  
 
Administrative Information
NCT Number NCT02156765
Other Study ID Numbers TTYY-20140410
Has Data Monitoring Committee Yes
U.S. FDA-regulated Product Not Provided
IPD Sharing Statement Not Provided
Responsible Party yongjun wang, Ministry of Science and Technology of the People´s Republic of China
Study Sponsor yongjun wang
Collaborators Not Provided
Investigators
Principal Investigator: yongjun wang, doctor Tiantan Hospital
PRS Account Ministry of Science and Technology of the People´s Republic of China
Verification Date June 2014